688002:SSERaytron Technology Co., Ltd. Class A Analysis
Data as of 2026-06-13 - not real-time
CN¥129.90
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Raytron Technology trades at ¥129.9, comfortably above its 20‑day (¥128.32) and 50‑day (¥128.66) simple moving averages, yet the MACD remains bearish with a negative histogram, suggesting limited upside momentum. The RSI sits near the neutral zone at 51.7, and the stock is hovering between a support of ¥114.52 and resistance near ¥139.20, while volume is on an upward trend. Valuation metrics are stretched: a trailing P/E of 42.6 exceeds the industry average of 36.8, the price‑to‑book is 8.18, and a discounted cash‑flow model caps fair value at only ¥55.34, indicating the market is pricing in aggressive growth expectations. Fundamentals, however, are robust – revenue surged 71% YoY, gross margin sits at 51.4%, ROE is 20.6%, and the balance sheet shows ample cash (¥2.47 bn) versus modest debt (¥1.30 bn). The dividend is modest (0.12%) with a very low payout ratio (5.3%), underscoring sustainability. Volatility is high at 48% over the past 30 days, but beta is low (0.27), reflecting limited systematic risk.
Given the overvalued pricing, neutral technical stance, and strong growth fundamentals, the stock appears poised for a correction before any further upside can be justified. Investors should watch for price moves toward the support zone and monitor macro‑policy signals in China’s technology sector, which could affect regulatory and geographic risk. The dividend’s safety and solid cash generation support a longer‑term view, but short‑term positioning should be defensive until valuation aligns with fundamentals.
Given the overvalued pricing, neutral technical stance, and strong growth fundamentals, the stock appears poised for a correction before any further upside can be justified. Investors should watch for price moves toward the support zone and monitor macro‑policy signals in China’s technology sector, which could affect regulatory and geographic risk. The dividend’s safety and solid cash generation support a longer‑term view, but short‑term positioning should be defensive until valuation aligns with fundamentals.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Bearish MACD histogram indicating weakening momentum
- Current price well above short‑term moving averages but near resistance
- Extreme overvaluation relative to DCF fair value
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Strong revenue growth (71% YoY) and high operating margins
- Robust cash position with low debt-to-equity
- Valuation still stretched, requiring price correction before upside
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Strategic exposure to high‑growth IR imaging and MEMS markets
- Sustainable dividend and low payout ratio
- Solid ROE and cash generation supporting future expansion
Key Metrics & Analysis
Financial Health
Revenue Growth71.10%
Profit Margin20.49%
P/E Ratio42.6
ROE20.63%
ROA9.11%
Debt/Equity17.93
P/B Ratio8.2
Op. Cash FlowCN¥2.6B
Free Cash FlowCN¥685.4M
Industry P/E36.8
Technical Analysis
TrendNeutral
RSI51.7
SupportCN¥114.52
ResistanceCN¥139.20
MA 20CN¥128.32
MA 50CN¥128.66
MA 200CN¥100.07
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair ValueCN¥55.34
GradeOvervalued
TypeGrowth
Dividend Yield0.12%
Risk Assessment
Beta0.27
Volatility48.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.